GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract HHSN272201400053CVAXINE PTY LTD

Overview

Award facts

Net obligations
$11.28M
$11,281,569of $11.28M potential value
Outlays (paid to date)
$500K
$500K paid of $11.28M obligated$500,000
Period of performance
Sep 23, 2014 to Sep 29, 2021
Ended
Modifications
14
Latest action Nov 24, 2021
Contract type
Definitive contract
PIID HHSN272201400053C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF ADJUVANT DISCOVERY PROGRAM

Dates and value

Award date
Signed on Sep 23, 2014
Potential end of performance
Sep 28, 2021
Current value
$11,281,569Base and exercised options
Potential value (if all options are exercised)
$11,281,569

Obligations by fiscal year of action

  • FY2022: -$4,922 (de-obligation)
  • FY2020: $500,000
  • FY2019: $413,000
  • FY2018: $1,904,860
  • FY2017: $320,000
  • FY2016: $400,000
  • FY2014: $7,748,631

Total across 7 fiscal years: $11,281,569

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 24, 2021. View on USAspending · Recipient on SAM.gov

Recipient

LocationBEDFORD PARK, AUS
UEIZ9AUC2SNX5A4
CAGE codeZ0ED5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org
Parent companyVAXINE PTY LTD

Business types and certifications

Foreign-ownedFor-profit organizationInternational organization

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Australia

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
16

Contract details

Subcontracting plan
Plan required - incentive not includedC
Major program
Adjuvant discovery program
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 23, 2014Base obligation at award: $7,748,631
Latest action
Nov 24, 2021 — CloseoutModification P00014; obligation change -$4,922; administrative: no change in scope or value
Latest substantive action
Apr 7, 2020 — Change orderModification P00013; obligation change +$500,000
Actions by type
  • Base award1
  • Change order6
  • Other administrative action6
  • Option exercised1
  • Closeout1
15 actions recorded, Sep 23, 2014 to Nov 24, 2021; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$4,922
Latest action: change in base and all options
-$4,922

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Contingency, humanitarian or peacekeeping operation
Presidential issued emergency declaration, or a major disaster declarationC

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
AustraliaAUS
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
15

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2017/2017-0885-000
  • 075-2018/2018-0885-000
  • 075-2019/2019-0885-000
  • 075-2020/2024-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$500,000
COVID-19 supplemental outlays
$500,000